Addressing chemoresistance with a lipid gemcitabine nanotherapeutic strategy for effective treatment of pancreatic cancer
Resistance to gemcitabine in pancreatic cancer poses a significant clinical challenge. Further investigation is warranted to assess whether nano-formulation strategy can be employed to enhance the sensitivity of resistant strains to gemcitabine therapy. In this study, using gemcitabine-resistant pan...
Saved in:
Published in | Nano research Vol. 17; no. 9; pp. 8377 - 8388 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Beijing
Tsinghua University Press
01.09.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!